Package 69097-861-12

{"route": ["ORAL"], "spl_id": "37025923-f696-46ab-95fb-b38c30e6004b", "openfda": {"nui": ["N0000175753", "N0000008486", "M0020790", "N0000000235", "N0000185503"], "upc": ["0369097861070"], "unii": ["459384H98V"], "rxcui": ["314285"], "spl_set_id": ["e8f368cb-6a07-4178-95fa-1d5a209171ed"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (69097-861-07)", "package_ndc": "69097-861-07", "marketing_start_date": "20160713"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (69097-861-12)", "package_ndc": "69097-861-12", "marketing_start_date": "20160713"}], "brand_name": "zonisamide", "product_id": "69097-861_37025923-f696-46ab-95fb-b38c30e6004b", "dosage_form": "CAPSULE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Carbonic Anhydrase Inhibitors [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "P-Glycoprotein Inhibitors [MoA]", "Sulfonamides [CS]"], "product_ndc": "69097-861", "generic_name": "zonisamide", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "zonisamide", "active_ingredients": [{"name": "ZONISAMIDE", "strength": "100 mg/1"}], "application_number": "ANDA077869", "marketing_category": "ANDA", "marketing_start_date": "20160713", "listing_expiration_date": "20261231"}